C5AR1 and acute respiratory distress syndrome: (6) There was a significant (p < 0.0001) difference in the % C5aR1-expressing monocytes between pneumonia (non-COVID-19) patients and ARDS (COVID-19) patients at the passage of time mentioned above, with a large effect size (d = 1.87).